The protein levels of BRD2, BRD3, and BRD4 has been diminished by most impactive BRD PROTAC, dBET1, with less nanomolar efficacy and surpassed JQ1 for activating of apoptosis in cell lines of AML and lymphoma.243. Here, BRD4 is linked to acute myeloid leukemia.